Response to Letter Regarding Article, “Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis: A Prospective Study From the International Collaboration on Endocarditis”
Vivian H. Chu(Duke Medical Center), Andrew Wang(Georgia Institute of Technology), Hussien Rizk(Instituto Nacional de Cardiologia), Christophe Tribouilloy(Centre Hospitalier Universitaire Amiens-Picardie), Nuria Fernández‐Hidalgo, Cristiane da Cruz Lamas(Instituto Nacional de Cardiologia), Emanuele Durante‐Mangoni(University of Campania "Luigi Vanvitelli"), Efthymia Giannitsioti(Instituto Nacional de Cardiologia), Juan M. Pericàs(Hospital Clínic de Barcelona), Tomáš Freiberger(Masaryk University), John P. Hurley, Lawrence P. Park(Duke University), Vladimir Krajinović(Instituto Nacional de Cardiologia), Eugene Athan(Barwon Health), José M. Miró(Universitat Autònoma de Barcelona), François Delahaye(Hospices Civils de Lyon), Margaret M. Hannan(Mater Misericordiae Hospital), Francisco Nacinovich(Instituto Cardiovascular de Buenos Aires), Daniel W. Mudrick(OhioHealth), Jacob Strahilevitz(Hebrew University of Jerusalem)
Cited by 2
Related Papers
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
|Nature Medicine|2005|1k
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
|Clinical Microbiology Reviews|2009|930
<i>qnr</i> Prevalence in Ceftazidime-Resistant <i>Enterobacteriaceae</i> Isolates from the United States
|Antimicrobial Agents and Chemotherapy|2006|576